cd38 inhibitor and 5-amino-1mq combination benefits Anti-CD38 antibody therapy for patients with relapsed/refractory multiple myeloma: differential mechanisms of action recent clinical trial outcomes | Annals of Hematology Frontiers | Counterproductive effects of
Frontiers Counterproductive effects of anti CD38 and checkpoint inhibitor for the treatment of NK T cell lymphoma Inhibition of CD38 enzymatic activity enhances CAR T cell immune therapeutic efficacy by repressing glycolytic metabolism ScienceDirect Immunomodulatory properties of CD38 antibodies and their effect on anticancer efficacy in multiple myeloma Bisht 2023 Cancer Medicine Wiley Online Library Frontiers Nicotinamide N methyltransferase (NNMT): a novel therapeutic target for metabolic syndrome Evolving Therapeutics in Multiple Myeloma Empower MM
Pay in 4 interest-free payments of $5.63 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 14 - Oct 19




